There are many diverse mechanisms by which these compounds could affect leukemias such as inhibition or blockage of signal transduction pathways, inhibiting key enzymes, e.g., COX-2 activity, a rate-limiting enzyme for the synthesis of prostaglandins, which are involved in the proliferation and differentiation of leukemia cells and ROS production. This evidence concerns the gene PTGS2 and leukemia.